John Libbey Eurotext

Médecine de la Reproduction

MENU

What face for Medically Assisted Procreation with a third-party donor after the vote of the bioethics law in 2021? The questioning of the Cecos biologists Volume 24, issue 3, Juillet-août-septembre 2022

Authors
1 Univ Rouen Normandie Univ, UniRouen, EA 4308 “Gametogenesis and Gamete Quality”, Rouen University Hospital, Biology of Reproduction-Cecos Laboratory, Rouen, France
2 AP-HM Hôpital La Conception, Pôle femmes-parents-enfants, centre clinicobiologique d’assistance médicale à la procréation-Cecos, Marseille, France
3 Aix Marseille Univ, Inserm, MMG, U1251, Marseille Medical Genetics, Marseille, France
4 Biologie de la reproduction, Cecos, hôpital Cochin, AP-HP Centre, université de Paris, Paris, France
5 Cecos Paris Jean-Verdier, Hôpital Jean Verdier, Paris, France
6 Cecos Picardie, CHU d’Amiens, Amiens, France
7 Cecos Franche-Comté Bourgogne Besançon, CHU de Besançon, Besançon, France
8 Cecos Pays de Loire, site de Nantes, CHU de Nantes, Nantes, France
9 Cecos Paris Clamart, hôpital Antoine Béclère, Clamart, France
* Tirés à part : N. Rives

The revised bioethics law was promulgated in August 2021. It opens up novel rights for female couples and single women who can benefit from medically Assisted Procreation (PMA) with a third-party donor. In addition, it also allows the principle of access to origins to persons conceived by donation who request it and obliges candidates for gamete or embryo donation to register in this obligation. The revised law makes it possible to store gametes outside medical indications for both women and men. All of these new rights have major repercussions in the organization of donation centers and more specifically in Cecos given the unanticipated extent of new uses of ART with third-party donors. An adaptation of care pathways seems necessary as well as interactions between the professionals of the donation centers and the new applicants to best meet the expectations of each of the stakeholders.